355. Claudia Nari on Inari’s unique advantage + gene editing as a new paradigm in agbioscience
Gene editing in plants – it's been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, j
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Gene editing in plants – it's been heralded as the next step-function change in the advancement of agriculture. One Indiana company is advancing the technology fresh off a $144 million venture capital raise. Claudia Nari, Chief Product Officer of Inari, joins today to talk through this historic time for gene editing and biotechnology at large. They get into:
- From speed to precision, Claudia lays out the differentiation of gene editing to other types of plant breeding
- Crops of focus for Inari right now and stresses they’re focused on to enable farmer success
- The company’s recent venture capital raise, their value proposition and educating investors
- Inari’s unique advantage (knowing what to do, having the tools to do it and being able to do those at the same time)
- The status of field trials and what commercialization will look like for Inari
- Biggest problems in-field to be solved through gene editing – from yield to resource efficiencies
- Regulatory hurdles and Claudia’s perspective on the acceptance of gene editing as a technology
- When will Inari technology be in customer fields? And what’s next?